Farmacja Polska,
Journal Year:
2023,
Volume and Issue:
79(6), P. 347 - 354
Published: Oct. 26, 2023
Mikrobiota
jelitowa
tworzy
kompleksowy
i
aktywny
metabolicznie
ekosystem.
Zmiany
w
aktywności
mikrobioty
jelitowej
korelują
ze
stanem
zdrowia.
Nie
wiadomo,
czy
zaburzenia
funkcjonowania
spowodowane
niepożądanymi
zmianami
składu
jakościowego
ilościowego
(tzw.
dysbioza)
są
przyczyną,
skutkiem
występowania
stanów
chorobowych.
Długoterminowe
nawyki
żywieniowe
odgrywają
kluczową
rolę
tworzeniu
specyficznej
dla
człowieka.
Pomimo
wielu
publikacji
na
temat
wpływu
węglowodanów
o
właściwościach
prebiotycznych,
wpływ
tłuszczów
diecie,
takich
jak
wielonienasycone
kwasy
tłuszczowe
omega-3
(WNKT),
mikrobiotę
jelitową
jest
mniej
poznany.
Głównymi
formami
bioaktywnymi
u
ludzi
spośród
WNKT
omega-3,
kwas
eikozapentaenowy
(EPA,
C20:5)
oraz
dokozaheksaenowy
(DHA,
C22:6).
Związki
te
istotną
prawidłowym
funkcjonowaniu
organizmu
człowieka,
a
także
profilaktyce
terapii
chorób,
dlatego
powszechnie
stosowane
jako
nutraceutyki.
Nieliczne
badania
przeprowadzone
z
udziałem
osób
dorosłych
wykazały
zmiany
po
suplementacji
zmniejszenie
dysbiozy.
mogą
zmieniać
skład
liczebność
mikrobiomu
jelitowego,
drugiej
strony
mikroorganizmy
jelitowe
wpływać
metabolizm
wchłanianie
tych
związków.
Kwasy
wpływają
mikrobiom
jelitowy
trzy
główne
sposoby:
modulując
rodzaj
drobnoustrojów
jelitowych,
zmieniając
poziomy
mediatorów
prozapalnych,
endotoksyny
(lipopolisacharydy)
interleukina
17;
regulując
krótkołańcuchowych
kwasów
tłuszczowych
(SCFA).
Celem
pracy
było
podsumowanie
aktualnego
stanu
wiedzy
biologicznej
jelitowej,
szczególności
oddziaływań
mikrobiota
ludzi.
Wyszukiwanie
danych
przeprowadzono
lipcu
2023
r.
bazie
PubMed
dostępnej
literaturze
użyciem
terminów:
"intestinal
microbiota",
"microbiome",
"omega-3
polyunsaturated
acids
intestinal
"EPA
"DHA
microbiota".
W
artykule
omówiono
oddziaływania
pomiędzy
mikrobiotą
omega-3.
Przedstawione
zagadnienia
pozwalają
wnioskować,
że
wyjaśnienie
mechanizmów
interakcji
stwarza
podstawy
do
opracowania
skutecznych
interwencji
terapeutycznych.
ACS Chemical Neuroscience,
Journal Year:
2023,
Volume and Issue:
14(6), P. 1045 - 1062
Published: March 3, 2023
The
gut-brain
axis
(GBA)
is
the
umbrella
term
to
include
all
bidirectional
communication
between
brain
and
gastrointestinal
(GI)
tract
in
mammalian
body.
Evidence
from
over
two
centuries
describes
a
significant
role
of
GI
microbiome
health
disease
states
host
organism.
Short-chain
fatty
acids
(SCFAs),
mainly
acetate,
butyrate,
propionate
that
are
physiological
forms
acetic
acid,
butyric
propionic
acid
respectively,
bacteria
derived
metabolites.
SCFAs
have
been
reported
influence
cellular
function
multiple
neurodegenerative
diseases
(NDDs).
In
addition,
inflammation
modulating
properties
make
them
suitable
therapeutic
candidates
neuroinflammatory
conditions.
This
review
provides
historical
background
GBA
current
knowledge
individual
central
nervous
system
(CNS)
disorders.
Recently,
few
reports
also
identified
effects
metabolites
case
viral
infections.
Among
these
viruses,
flaviviridae
family
associated
with
neuroinflammation
deterioration
CNS
functions.
this
context,
we
additionally
introduce
SCFA
based
mechanisms
different
pathogenesis
understand
former's
potential
as
agents
against
flaviviral
disease.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(15), P. 8250 - 8250
Published: July 28, 2024
The
intricate
relationship
between
the
gastrointestinal
(GI)
microbiome
and
progression
of
chronic
non-communicable
diseases
underscores
significance
developing
strategies
to
modulate
GI
microbiota
for
promoting
human
health.
administration
probiotics
prebiotics
represents
a
good
strategy
that
enhances
population
beneficial
bacteria
in
intestinal
lumen
post-consumption,
which
has
positive
impact
on
In
addition,
dietary
fibers
serve
as
significant
energy
source
inhabiting
cecum
colon.
Research
articles
reviews
sourced
from
various
global
databases
were
systematically
analyzed
using
specific
phrases
keywords
investigate
these
relationships.
There
is
clear
association
fiber
intake
improved
colon
function,
gut
motility,
reduced
colorectal
cancer
(CRC)
risk.
Moreover,
state
health
reflected
reciprocal
bidirectional
relationships
among
food,
antioxidants,
inflammation,
body
composition.
They
are
known
their
antioxidant
properties
ability
inhibit
angiogenesis,
metastasis,
cell
proliferation.
Additionally,
they
promote
survival,
immune
inflammatory
responses,
inactivate
pro-carcinogens.
These
actions
collectively
contribute
role
prevention.
different
investigations,
supplements
containing
vitamins
have
been
shown
lower
risk
types.
contrast,
some
evidence
suggests
taking
can
increase
cancer.
Ultimately,
collaborative
efforts
immunologists,
clinicians,
nutritionists,
dietitians
imperative
designing
well-structured
nutritional
trials
corroborate
clinical
efficacy
therapy
managing
inflammation
preventing
carcinogenesis.
This
review
seeks
explore
interrelationships
fiber,
microbiome,
with
particular
focus
potential
implications
Microorganisms,
Journal Year:
2022,
Volume and Issue:
10(12), P. 2405 - 2405
Published: Dec. 5, 2022
The
gut
microbiota,
which
represent
a
community
of
different
microorganisms
in
the
human
intestinal
tract,
are
crucial
to
preserving
health
by
participating
various
physiological
functions
and
acting
as
metabolic
organ.
In
conditions,
microbiota-host
partnership
exerts
homeostatic
stability;
however,
changes
microbiota
composition
(dysbiosis)
an
important
factor
pathogenesis
inflammatory
bowel
disease
its
two
main
entities:
ulcerative
colitis
Crohn's
disease.
incidence
prevalence
these
conditions
have
increased
rapidly
last
decade,
becoming
significant
problem
for
healthcare
system
true
challenge
finding
novel
therapeutic
solutions.
issue
is
that,
despite
numerous
studies,
etiopathogenesis
not
completely
clear.
Based
on
current
knowledge,
chronic
inflammation
occurs
due
altered
environmental
factors,
well
complex
interplay
between
genetic
predisposition
host
inappropriate
innate
acquired
immune
response.
It
note
that
development
biological
immunomodulatory
therapy
has
led
progress
treating
Certain
lifestyle
approaches-including
fecal
transplantation
nutritional
supplementation
with
probiotics,
prebiotics,
synbiotics-have
offered
solutions
dysbiosis
management
paved
way
towards
restoring
healthy
microbiome,
only
minimal
long-term
unfavorable
effects.
Nutrients,
Journal Year:
2023,
Volume and Issue:
15(9), P. 2097 - 2097
Published: April 27, 2023
Describing
diet-related
effects
on
the
gut
microbiome
is
essential
for
understanding
its
interactions
with
fat
and/or
sugar-rich
diets
to
promote
obesity-related
metabolic
diseases.
Here,
we
sequenced
V3-V4
hypervariable
region
of
bacterial
16S
rRNA
gene
study
composition
and
dynamics
adult
mice
fed
rich
in
sugar,
at
9
18
weeks
diet.
Under
high-fat,
high-sugar
diet,
abundances
Frontiers in Nutrition,
Journal Year:
2023,
Volume and Issue:
9
Published: Jan. 6, 2023
Although
a
general
healthy
gut
microbiota
cannot
be
defined
due
to
numerous
internal
and
external
individual
factors,
such
as
sex,
age,
ethnicity,
genetics,
environment,
diet
drugs
affect
its
composition,
certain
microbial
species
compositions
seem
related
the
progression
of
insulin
resistance
type
2
diabetes,
well
development
microvascular
macrovascular
complications
diabetes.
The
present
review
aimed
at
gathering
reported
information
describing
how
resveratrol
induced
changes
in
composition
can
mediate
positive
effects
this
polyphenol
on
glucose
homeostasis
under
diabetic
conditions,
both
animals
humans.
Based
fact
that
some
observed
patients
are
reversed
by
treatment,
taking
into
account
mediated
similar
those
anti-diabetic
metformin,
it
proposed
four
genera,
Alistipes,
Allobaculum,
Desulfovibrio
Blautia
could
involved
benefits
glycameic
control.
Nevertheless
limitations
research
field:
(a)
number
studies
analyzing
same
cohort
animals,
order
know
potential
involvement
phenolic
compound,
very
scarce
practically
inexistent
case
humans.,
(b)
inconsistencies
concerning
changes,
(c)
experimental
design
used
do
not
allow
researchers
establish
causal
relationship
between
effect,
vast
majority
studies,
(d)
knowledge
about
role
each
bacteria
glycaemic
control
is
sufficient
so
far.
Digestive Diseases and Sciences,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 4, 2024
In
inflammatory
bowel
diseases
(IBD),
the
most
promising
therapies
targeting
cytokines
or
immune
cell
trafficking
demonstrate
around
40%
efficacy.
As
IBD
is
a
multifactorial
inflammation
of
intestinal
tract,
single-target
approach
unlikely
to
solve
this
problem,
necessitating
an
alternative
strategy
that
addresses
its
variability.
One
often
overlooked
by
pharmaceutically
driven
therapeutic
options
address
impact
environmental
factors.
This
somewhat
surprising
considering
increasingly
viewed
as
condition
heavily
influenced
such
factors,
including
diet,
stress,
and
pollution-often
referred
"Western
lifestyle".
IBD,
responses
result
from
complex
interplay
among
genetic
background
patient,
molecules,
cells,
local
microenvironment
where
danger-
microbe-associated
molecular
patterns
(D/MAMPs)
provide
adjuvant-rich
environment.
Through
activating
DAMP
receptors,
array
pro-inflammatory
factors
can
stimulate,
for
example,
NLRP3
inflammasome-a
major
amplifier
response
in
various
cells
via
non-specific
bystander
activation
myeloid
(e.g.,
macrophages)
lymphocytes
tissue-resident
memory
T
cells).
Current
biological
treatment
approaches
dampen
response,
but
without
reducing
exposure
e.g.,
changing
diet
(reducing
ultra-processed
foods),
landscape
never
resolved
continues
drive
mucosal
dysregulation.
Thus,
are
not
enough
put
out
fire.
The
resultant
smoldering,
low-grade
diminishes
physiological
resilience
(micro)environment,
perpetuating
state
chronic
disease.
Therefore,
our
hypothesis
posits
successful
interventions
must
complexity
disease
simultaneously
all
modifiable
aspects:
innate
immunity
microbiota,
adaptive
cytokines,
relate
(micro)environment.
Thus
be
comprehensively
treated
across
nano-,
meso-,
microscales,
rather
than
with
focus
on
single
targets.
A
broader
perspective
also
includes
adapt
DAMPing
(micro)environment
warranted.
World Journal of Cardiology,
Journal Year:
2025,
Volume and Issue:
17(4)
Published: April 21, 2025
Integrating
exhaled
breath
analysis
into
the
diagnosis
of
cardiovascular
diseases
holds
significant
promise
as
a
valuable
tool
for
future
clinical
use,
particularly
ischemic
heart
disease
(IHD).
However,
current
research
on
volatilome
(exhaled
composition)
in
remains
underexplored
and
lacks
sufficient
evidence
to
confirm
its
validity.
Key
challenges
hindering
application
diagnosing
IHD
include
scarcity
studies
(only
three
published
papers
date),
substantial
methodological
bias
two
these
studies,
absence
standardized
protocols
implementation.
Additionally,
inconsistencies
methodologies-such
sample
collection,
analytical
techniques,
machine
learning
(ML)
approaches,
result
interpretation-vary
widely
across
further
complicating
their
reproducibility
comparability.
To
address
gaps,
there
is
an
urgent
need
establish
unified
guidelines
that
define
best
practices
data
analysis,
ML
integration,
biomarker
annotation.
Until
are
systematically
resolved,
widespread
adoption
reliable
diagnostic
distant
goal
rather
than
imminent
reality.
Advanced Gut & Microbiome Research,
Journal Year:
2025,
Volume and Issue:
2025(1)
Published: Jan. 1, 2025
The
human
microbiota
is
one
of
the
most
powerful
sites
for
antibiotic
resistance
(AR)
genes.
It
home
to
thousands
microbes
at
various
stages
development.
complex
inner
environment
has
potential
affect
host’s
immunity,
metabolism,
and
genetic
makeup.
gut
an
incredibly
high
level
gene
diversity.
Its
3.3
million
nonredundant
genes
even
outnumber
150
total
genomes.
In
gut,
where
10–100
trillion
diversity‐enhanced
microbe
cells
reside,
horizontal
transfer
(HGT)
prevalent
occurs
a
rate
approximately
25
times
higher
than
in
any
other
ecosystem.
AR
threatens
global
health
by
causing
stronger
infection
rates
death
tolls.
nonmedical
setting
that
aids
spread
antimicrobial
(AMR)
microbiome.
Antibiotic
(ARGs)
from
commensal,
anthropogenic,
environmental
make
up
resistome.
evolutionary
force
use
antibiotics
agriculture
medicine
increases
AMR.
dynamics
AMR
are
significantly
influenced
diverse
microbial
phyla
microbiota.
Within
gastrointestinal
tract,
ARGs
traded
transferred
between
bacterial
species
quite
often.
This
emphasizes
how
important
it
we
understand
body
functions
on
inside
as
well
outside
sources
infections.
could
potentially
come
oral
Even
absence
direct
selection
pressure,
linked
can
still
be
expressed
there.
epidemic
claims
millions
lives
poses
serious
risk
public
economy.
Bacterial
evolution,
overuse
misuse,
genetically
modified
foods,
drug‐resistant
pathogens
through
international
travel
possibly
contributing
Sustaining
requires
surveillance,
which
hampered
inadequate
data
collection,
knowledge
gaps,
low
awareness.
addition
raising
rates,
also
raises
healthcare
costs,
diminishes
treatment
effectiveness,
promotes
growth
bacteria.
Without
considering
agriculture,
gap,
or
proper
antibiotics,
biological
factors
have
contributed
escalation
research
summarizes
current
gaps
antimicrobial‐
antibiotic‐resistant
contribution
AR.